Table 1.
Patient demographics and baseline characteristics
| Patient no. | Sex | Age | Unilateral | Evolution (months) | Treatment |
|---|---|---|---|---|---|
| 1 |
F |
10 |
Yes |
96 |
LH |
| 2 |
M |
12 |
No |
30 |
LH |
| 3 |
F |
7 |
Yes |
15 |
LH + steroids |
| 4 |
F |
10 |
Yes |
8 |
LH + steroids |
| 5 |
F |
7 |
Yes |
15 |
LH |
| 6 |
F |
8 |
No |
69 |
LH |
| 7 |
M |
15 |
Yes |
18 |
LH + steroids |
| 8 |
F |
14 |
Yes |
20 |
LH |
| 9 |
F |
6 |
Yes |
10 |
LH + ERY |
| 10 |
F |
16 |
No |
90 |
LH |
| 11 |
M |
5 |
Yes |
12 |
LH + steroids |
| 12 |
F |
10 |
Yes |
15 |
LH |
| 13 |
M |
5 |
Yes |
27 |
LH + steroids |
| 14 |
F |
7 |
Yes |
24 |
LH + steroids |
| 15 |
M |
4 |
Yes |
20 |
LH |
| 16 | M | 15 | Yes | 148 | LH |
LH, lid hygiene; ERY, oral erythromycin.